semaglutide asa guidelines Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement PERIOPERATIVE GLP-1: ASA vs. GASTROENTEROLOGISTS

PMID: 31446075

The increased risk of kidney stones, on the other hand, might be less familiar

These side effects primarily stem from the medications impact on digestion and nutrient absorption: Nausea Vomiting Diarrhea Decreased appetite These symptoms could lead to dehydration and electrolyte imbalances if not managed properly, situations that can make one feel cold or experience chill-like sensations

Contact us for guidance

Aplastic Anemia This rare but serious type occurs when the bone marrow does not produce enough red blood cells

If cholelithiasis is suspected, gallbladder studies and appropriate clinical follow-up are indicated Hypoglycemia: Adult patients with type 2 diabetes on an insulin secretagogue (eg, a sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia with use of Saxenda